Sleep related epilepsy and pharmacotherapy: An insight

Jaya Kumar, Amro Solaiman, Pasuk Mahakkanukrauh, Rashidi Mohamed, Srijit Das*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

15 Citations (Scopus)


In the last several decades, sleep-related epilepsy has drawn considerable attention among epileptologists and neuroscientists in the interest of new paradigms of the disease etiology, pathogenesis and management. Sleep-related epilepsy is nocturnal seizures that manifest solely during the sleep state. Sleep comprises two distinct stages i.e., non-rapid eye movement (NREM) and rapid eye movement (REM) that alternate every 90 min with NREM preceding REM. Current findings indicate that the sleep-related epilepsy manifests predominantly during the synchronized stages of sleep; NREM over REM stage. Sleep related hypermotor epilepsy (SHE), benign partial epilepsy with centrotemporal spikes or benign rolandic epilepsy (BECTS), and Panayiotopoulos Syndrome (PS) are three of the most frequently implicated epilepsies occurring during the sleep state. Although some familial types are described, others are seemingly sporadic occurrences. In the present review, we aim to discuss the predominance of sleep-related epilepsy during NREM, established familial links to the pathogenesis of SHE, BECTS and PS, and highlight the present available pharmacotherapy options.

Original languageEnglish
Article number1088
Pages (from-to)1-17
Number of pages17
JournalFrontiers in Pharmacology
Publication statusPublished - Sept 2018


  • Epilepsy
  • PS
  • Panayiotopoulos
  • Rolandic
  • SHE
  • Seizure
  • Sleep

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Sleep related epilepsy and pharmacotherapy: An insight'. Together they form a unique fingerprint.

Cite this